An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Clinical trial NCT07420010 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07420010
- Sponsor
- Weijia Fang, MD
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-15
- Primary completion
- 2028-12-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.